(Press-News.org) Remarkable improvements in cancer survival mean that half of all people diagnosed with cancer today (2010-11) in England and Wales are expected to survive from their cancer for at least 10 years, compared to just a quarter of people diagnosed 40 years ago (1971-72), according to a new index of survival for all cancers combined*, published in The Lancet.
However, although some cancers have a good prognosis, the outlook for others remains extremely poor. For example, while 98% of men with testicular cancer survive from their cancer for at least a decade after diagnosis, up from 69% 40 years ago, just 1% of pancreatic cancer patients diagnosed today are expected to survive from their cancer 10 years.
Led by the Cancer Research UK Cancer Survival Group at the London School of Hygiene & Tropical Medicine, London, UK, the researchers analysed survival trends for more than 7 million adults (aged 15 to 99 years) diagnosed with one of 21 common cancers in England and Wales between 1971 and 2011, and followed up to the end of 2012.
The 21 cancers clearly divided into three groups with either high, moderate, or low survival. The groups have remained much the same for 40 years (see Article figure 2, page 8).
For cancers of the brain, stomach, lung, oesophagus, and pancreas, 10-year survival after diagnosis is still below 15%. There has been little or no improvement in long-term survival from these diseases since the early 1970s. Even today, only 5% of those diagnosed with lung cancer are expected to survive from their cancer for 10 years after diagnosis. Despite more than doubling in the last 40 years, 10-year survival for people diagnosed with a brain tumour also remains very low at 14% (see tables 2 and 3, pages 4-7).
"These five cancers impose a huge public health burden, both because they are common and because they are often diagnosed at a late stage, when they are much harder to treat"**, explains lead author Dr Bernard Rachet from the London School of Hygiene & Tropical Medicine.
"For three of these cancers (lung, stomach, and oesophagus), surgery is often the key treatment, but patients are often diagnosed too late for surgery with a realistic prospect of cure. Even for those patients who are diagnosed early, surgery is not always performed. We should be carrying out surgical treatment for many more patients than is currently the case. When it comes to lung cancer, for example, almost all patients diagnosed at an early stage of disease should be operated on with curative intent."**
Survival to ten or more years after diagnosis is generally above 70% for cancers of the breast, prostate, testis, and uterus, and for melanoma and Hodgkin's disease, and improvement in survival is greatest for these cancers. For example, more than three-quarters (78%) of women with breast cancer are now surviving from their cancer for at least 10 years after diagnosis, up from 40% in the early 1970s. For people diagnosed with melanoma, 10-year survival has almost doubled in the last 40 years, rising from 46% to 90% (see tables 2 and 3, pages 4-7).
The analysis also confirms a persistent "age gap" in survival between younger and older patients for all cancers. Dr Rachet explains, "Even after we have adjusted for the fact that older people have much higher death rates from other diseases than younger people, elderly cancer patients are doing worse for all cancers. This problem is particularly marked in the UK--in other countries, the age gap in cancer survival has become much narrower over the last 15-20 years than in England and Wales."**
According to co-author Manuela Quaresma, also from the London School of Hygiene & Tropical Medicine, "Although survival for some cancers has improved dramatically over the past 40 years, others are lagging far behind. More investment is urgently needed to improve early diagnosis and provide the best treatment, including more specialist surgeons, for poor-prognosis cancers like lung cancer, which have shown little or no evidence of improvement in long-term survival (5 and 10 years after diagnosis) over the past 40 years."**
INFORMATION:
NOTES TO EDITORS:
This study is funded by Cancer Research UK.
*The index of net survival for all cancers combined (49•8%) is a single number that reflects progress in the overall effectiveness of cancer management in England and Wales, including earlier diagnosis, more thorough investigation, and improved treatment and care. The index is designed to be independent of changes over time in the age profile of cancer patients, and changes in the proportion of cancers with high and low survival (see figure 1, page 3).
**Quotes direct from authors and cannot be found in text of Article.
A new study out today in the Journal of Neuroscience shows that traumatic brain injury can disrupt the function of the brain's waste removal system. When this occurs, toxic proteins may accumulate in the brain, setting the stage for the onset of neurodegenerative diseases such as Alzheimer's and chronic traumatic encephalopathy.
"We know that traumatic brain injury early in life is a risk factor for the early development of dementia in the decades that follow," said Maiken Nedergaard, M.D., D.M.Sc., co-director of the University of Rochester Center for Translational ...
A group of researchers tested whether monkeys show a common human bias: the tendency to confuse the price of a good with its quality. Previous studies have shown that humans think wine labeled with an expensive price tag tastes better than the same wine labeled with a cheaper price tag. In other studies, people thought a pain killer worked better when they paid a higher price for it.
"We know that capuchin monkeys share a number of our own economic biases. Our previous work has shown that monkeys are loss averse, irrational when it comes to dealing with risk, and even ...
In a new study published today in the journal Frontiers in Neurology, a team of researchers led by the University of Surrey, have identified a rogue protein in multiple sclerosis, which attacks the body's central nervous system. Researchers believe this finding could pave the way for better understanding of multiple sclerosis and new treatments against neurodegenerative diseases.
Scientists have previously known that rogue proteins cause brain damage in other diseases of the brain such as Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease.
In this study, scientists ...
Although some guidelines recommend use of bisphosphonates (a class of drugs used to strengthen bone) for men on androgen deprivation therapy, an analysis finds that prescriptions for these drugs remains low, even for those men at high risk of subsequent fractures, according to a study in the December 3 issue of JAMA.
Androgen deprivation therapy (ADT) is an effective, widely used therapy for men with prostate cancer. Adverse effects include bone loss and increased fracture risk. Canadian guidelines recommended bisphosphonate use in men with osteoporosis or fragility ...
In at least one respect, Capuchin monkeys are smarter than humans -- they don't assume a higher price tag means better quality, according to a new Yale study appearing in the open-access journal Frontiers in Psychology.
People consistently tend to confuse the price of a good with its quality. For instance, one study showed that people think a wine labeled with an expensive price tag tastes better than the same wine labeled with a cheaper price tag. In other studies, people thought a painkiller worked better when they paid a higher price for it.
The Yale study shows ...
Irvine, Calif., Dec. 2, 2014 - A comprehensive, 21-year analysis of the fastest-melting region of Antarctica has found that the melt rate of glaciers there has tripled during the last decade.
The glaciers in the Amundsen Sea Embayment in West Antarctica are hemorrhaging ice faster than any other part of Antarctica and are the most significant Antarctic contributors to sea level rise. This study is the first to evaluate and reconcile observations from four different measurement techniques to produce an authoritative estimate of the amount and the rate of loss over the ...
ARGONNE, Ill. ― A team of researchers from the U.S. Department of Energy's Argonne National Laboratory and Ohio University have devised a powerful technique that simultaneously resolves the chemical characterization and topography of nanoscale materials down to the height of a single atom.
The technique combines synchrotron X-rays (SX) and scanning tunneling microscopy (STM). In experiments, the researchers used SX as a probe and a nanofabricated smart tip of a STM as a detector.
Using this technique, researchers detected the chemical fingerprint of individual ...
West Orange, NJ. December 2, 2014. Stroke researchers have found that the presence of frontal lesions predicts better functional improvement in individuals with spatial neglect who received prism adaptation therapy. "Integrity of medial temporal structures may predict better improvement of spatial neglect with prism adaptation treatment" (doi: 10.1007/s11682-012-9200-5) was published in September in the Neuroimaging and Rehabilitation Special Issue of Brain Imaging & Behavior. The authors are Peii Chen, PhD, Priyanka Shah, and A.M. Barrett, MD, of Kessler Foundation, Kelly ...
To arrange for an interview with a researcher, please contact the Communications staff member identified at the end of each tip. For more information on ORNL and its research and development activities, please refer to one of our media contacts. If you have a general media-related question or comment, you can send it to news@ornl.gov.
IMAGING - Clearer brain scans ...
A clever signal noise reduction strategy developed by a team that includes Oak Ridge National Laboratory's Ben Lawrie could dramatically improve brain imaging. By using quantum correlated beams of light, ...
New Rochelle, NY, December 2, 2014--A study of active duty U.S. Marines who suffered a recent or previous concussion(s) examined whether persistent post-concussive symptoms (PPCS) and lingering effects on cognitive function are due to concussion-related brain trauma or emotional distress. The results are different for a recent concussion compared to a history of multiple concussions, according to the study published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available Open Access on the Journal of Neurotrauma ...
